Dr Reddy's and Merck Serono sew up oncology biosimilars alliance
13:20 EDT 6 Jun 2012 | SCRIP
Dr Reddy's Laboratories and Merck Serono, a unit of Merck KGaA, plan to co-develop, manufacture and commercialise a basket of oncology biosimilars, primarily focused on monoclonal antibodies (MAbs). The partnership, which marks.....
Original Article: Dr Reddy's and Merck Serono sew up oncology biosimilars alliance
More From BioPortfolio on "Dr Reddy's and Merck Serono sew up oncology biosimilars alliance"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
